about
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.The right to informed choice. A study and opinion poll of women who were or were not given the option of a sterilisation with their caesarean sectionExperience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey.Intrauterine contraception: study to evaluate clinical practice and to increase utilizationDuration of use of a levonorgestrel IUS amongst nulliparous and adolescent womenEvaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.Contraception in adolescence.Measuring the effects of unintended pregnancy on women's quality of life.Cost Effectiveness of Operative Versus Non-Operative Treatment of Geriatric Type-II Odontoid Fracture.Health-state utility values in breast cancer.Systematic review of the impact of urinary tract infections on health-related quality of life.Enhancing service delivery through title x funding: findings from California.Modelling cost-effectiveness of different vasectomy methods in India, Kenya, and Mexico.Cost-Effectiveness of a Family Planning Voucher Program in Rural Pakistan.Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population.Evaluation of the usefulness of the 'hormones with optional pelvic exam' programme offered at a family planning clinic.Pregnancy context and women's health-related quality of life.A qualitative analysis of long-acting reversible contraception.The short-term health and economic burden of gestational diabetes mellitus in China: a modelling study.Economic evaluation of using a genetic test to direct breast cancer chemoprevention in white women with a previous breast biopsy.Consideration Sets and Their Role in Modelling Doctor Recommendations About Contraceptives.What is the actual cost of providing the intrauterine system for contraception in a UK community sexual and reproductive health setting?Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda
P2860
Q33605175-06F294D2-CFC9-4130-823B-93AC746B185EQ33857188-B1D73F55-132F-4B53-AACA-AF69AB869248Q34415359-F90CB24D-2218-4AF8-82DD-C6FA5D9C0FBDQ35025605-DB9FE3AF-810F-4EA8-926B-32AB84115D01Q35435736-F1139075-F566-4D78-9D5E-15090F5A5F24Q35564876-2E875AE0-235D-438D-A330-700EF4FBD0E0Q36554644-50327B22-35BA-4544-B839-87B7E3600EAEQ36739167-89E1D986-26EF-4111-A212-7A54B83280B2Q36966272-1D4D9C89-A7CD-4C55-8739-0C30F1578748Q37025108-FCF3261C-B333-43B7-B175-51865E0AD9CAQ37800481-6F2B523F-5D2D-4567-89CB-1AE04B38282EQ38027883-0458F265-5E4F-4AF6-90C6-5A9C1123B966Q38411986-6A9B65AD-2D1C-41C7-A79A-811F508EF6A6Q42107992-808A7A22-FF3B-40BC-9B74-25B5F709D827Q42364560-9E846FB2-AA7F-4FF2-8D46-3AE6E3EADEBDQ44250124-B8242827-54BC-4F55-9E97-9E7F9472ADD1Q44974953-21983600-F83A-4D17-B895-863F5294FA37Q46028731-6A6C70F9-F8C0-44C5-BE8B-C96ECFC6A3F4Q46188956-5A500C19-B7CA-469C-BCB9-908AC536B2DAQ47137609-3D99403C-92E3-409F-A708-F998CD742370Q50460101-7746D0EC-F8E7-4BB3-899D-0840E5302946Q50786532-8973A71C-C2E0-4942-829E-134CE5184F70Q50857324-DBDBB2BA-E996-47AD-A00F-2BB30DF90EA8Q56910623-46A29359-C4BA-44CC-88E5-2D19E6D697B0
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Costs and net health effects of contraceptive methods.
@en
type
label
Costs and net health effects of contraceptive methods.
@en
prefLabel
Costs and net health effects of contraceptive methods.
@en
P2093
P1433
P1476
Costs and net health effects of contraceptive methods.
@en
P2093
C Greg Hagerty
Frank A Sonnenberg
Leon Speroff
Ronald T Burkman
Theodore Speroff
P304
P356
10.1016/J.CONTRACEPTION.2004.03.008
P577
2004-06-01T00:00:00Z